MarketWatch
US · 23 mins ago
Moderna’s stock doubles on promising cancer-vaccine results
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Do you trust MarketWatch?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!